View post: I'm a Former NFL Strength and Conditioning Coach—This Simple Interval Workout Boosts VO2 Max for Men Over 50 in Just Weeks I'm a Former NFL Strength and Conditioning Coach—This Simple ...

If you’ve seen ads for strength-building supplements, they may seem like a tempting shortcut. And there is some evidence that at least some "may help you build muscle and prevent the natural muscle ...

The first major update to resistance-training guidelines in 17 years delivers one clear message: any amount of resistance training improves strength, muscle size, power and physical function. The new ...

March 11 (Reuters) - Regenxbio (RGNX.O), opens new tab said on Wednesday that interim data from a early-to-mid stage study of its experimental gene therapy in patients with Duchenne muscular dystrophy ...

Findings in nonhuman primates demonstrated good safety and tolerability, supporting potential clinical trials in humans. Sarcomatrix’s lead therapeutic candidate, S969, showed functional benefit in ...

In recent decades, high-resolution ultrasound (HRUS) has revolutionized the morphological and structural evaluation of peripheral nerves and muscles, revealing details of the internal structure of the ...

When we lose weight, we don’t just lose body fat – we lose muscle, too. With millions of people now using weight loss drugs such as Wegovy and Ozempic, understanding what impact this muscle loss might ...

Introduction: It is generally accepted that the capillary network decreases with advancing age. The combined effect of resistance training (RT) and testosterone still needs to be elucidated. Objective ...

A blink of an eye seems natural and instantaneous, but is it? Without a functioning eyelid, the eye can become dry, irritated and eventually lose the ability to see clearly. Now, a team of UCLA ...

New research has identified the enzyme glutamate dehydrogenase 1 (GLUD1) as a new therapeutic target for Duchenne muscular dystrophy (DMD). In preclinical DMD mouse models, investigators demonstrated ...

Dyne Therapeutics Inc. presented their most recent work to advance novel therapeutics for facioscapulohumeral muscular dystrophy (FHSD). FSHD is an autosomal dominant genetic disorder characterized by ...